Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HEDGEPATH PHARMACEUTICALS INC

 SummaryChartsNewsCompany 
Company
HedgePath Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics for patients with certain cancers. The Company may also explore acquiring or licensing other therapeutics addressing unmet needs and orphan indications beyond cancer. The Company's preliminary focus is on the development of therapies for skin, lung and... 
More about the company
All news about HEDGEPATH PHARMACEUTICALS INC
2019HEDGEPATH PHARMACEUTICALS : Announces Name Change to INHIBITOR Therapeutics, Inc. and Tick..
PR
2019HEDGEPATH PHARMACEUTICALS : Provides Corporate Update for the Fourth Quarter and Year End ..
PR
2018HEDGEPATH PHARMACEUTICALS : Closes Second Tranche of Mayne Pharma Financing
PR
2018HEDGEPATH PHARMACEUTICALS : Announces Expanded Patent Coverage
PR
2018HEDGEPATH PHARMACEUTICALS : Secures New Funding from Mayne Pharma to Support BCCNS Clinica..
PR
2016HEDGEPATH PHARMACEUTICALS : BUYINS.NET Issues HedgePath Pharmaceuticals (HPPI) SqueezeTrig..
PR
2016HEDGEPATH PHARMACEUTICALS : Announces Completion of $5.5 Million Private Placement Offerin..
PR
2014HEDGEPATH PHARMACEUTICALS : Receives IND Clearance to Commence Development of its Proposed..
PR
2013HEDGEPATH PHARMACEUTICALS INC : HedgePath Pharmaceuticals Enters into Key Collaboration wi..
PR
More news
News in other languages on HEDGEPATH PHARMACEUTICALS INC

- No features available -

More news
Chart HEDGEPATH PHARMACEUTICALS INC
Duration : Period :
HedgePath Pharmaceuticals Inc Technical Analysis Chart | US42278K1025 | MarketScreener
Managers and Directors
Nicholas Jon Virca President & Chief Executive Officer
Garrison J. Hasara Chief Financial Officer, Secretary & Treasurer
William Mark Watson Chairman
Richard Dana Ono Independent Director
Robert D. Martin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HEDGEPATH PHARMACEUTICALS INC5.00%32
MODERNA, INC.234.60%141 099
LONZA GROUP AG31.93%60 646
IQVIA HOLDINGS INC.43.58%49 145
SEAGEN INC.0.22%31 933
CELLTRION, INC.-38.02%25 328